Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > PHIZER just bought Trillium ---for--

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Aug 23, 2021 4:33pm

357 Views

Post# 33749956

RE:RE:RE:PHIZER just bought Trillium ---for--

Quite correct gojotv, if this was a one trick pony sure 3B buyout would be adequate. When we're looking at Bladder, lung, brain and an all virus & pathogen destroyer then yes you are in the ballpark at 100 bucks a share! We just need irrefutable proof from this trial that it does what we believe.

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth